Determinant of Fetal Growth Retardation After Sleeve Gastrectomy: Involvement of Ghrelin

Last updated: August 3, 2023
Sponsor: Assistance Publique - Hôpitaux de Paris
Overall Status: Active - Recruiting

Phase

N/A

Condition

Weight Loss

Pregnancy Complications

Birth Defects

Treatment

N/A

Clinical Study ID

NCT05977790
APHP220714
  • Female

Study Summary

The aim of the study is to determine, in pregnant women who have undergone sleeve gastrectomy (SG), whether ghrelin changes could be involved in in utero growth restriction (IUGR) and whether therefore a correlation between maternal ghrelin levels and birth weight is observed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Woman previously operated of sleeve gastrectomy
  • Pregnant from 3 to 6 months
  • Having a mono-fetal pregnancy
  • Coming to consult in day hospital for a nutritional assessment

Exclusion

Exclusion Criteria:

  • Twin pregnancy
  • Identified cause of IUGR apart from those related to sleeve gastrectomy
  • Woman who has undergone another bariatric surgery technique
  • Lack of individual information and collection of the consent form
  • Problems of understanding
  • Lack of affiliation to a social security scheme or state medical aid
  • Patient benefiting from a legal protection measure (with guardians or curators)

Study Design

Total Participants: 50
Study Start date:
July 10, 2023
Estimated Completion Date:
July 31, 2025

Study Description

Bariatric surgery (BS) has developed rapidly in recent years and the candidates are predominantly women of childbearing age. A negative impact on fetal growth (FG), has been described after BS whose mechanisms are not elucidated. The sleeve gastrectomy (SG), the most commonly practiced BS technique, is supposed to induce fewer nutritional deficiencies than gastric bypass. This is why it seems to be the technique of choice for young women, although the lack of hindsight does not allow recommendations to be made.

However, latest work showed that birth weight (BW) was affected as much after SG as after RYGB (Roux-en-Y Gastric Bypass), with 50% of BW Z-score <0 and 19% of small newborns for gestational age. In addition, only weight gain during pregnancy and maternal protein status were related to BW, but these parameters explained only 16% and 8% of the variance of the BW Z-score, respectively, suggesting that other factors are therefore involved.

Sleeve gastrectomy induces the loss of the majority of gastric cells secreting ghrelin, an orexigenic hormone involved in the regulation of appetite but also in the pituitary secretion of growth hormone, which could influence fetal growth, as shown in a model of pregnant rats. However, no studies have evaluated the link between maternal ghrelin and pregnancy outcome in women undergoing bariatric surgery.

The study population will include pregnant women who have undergone bariatric surgery such as sleeve gastrectomy (which is currently the most frequently performed technique) before pregnancy, coming to consult between the 3rd and 6th month of pregnancy (2nd trimester) for a nutritional check-up in a day hospital.

Connect with a study center

  • Hopital Louis Mourier

    Colombes, 92025
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.